Positron emission tomography tracers for synucleinopathies
Abstract Synucleinopathies, such as Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy, are characterized by the aggregation of α-synuclein. Variations in brain distribution allow for differentiation among these diseases and facilitate precise clinical diagnosis. However, di...
Saved in:
| Main Authors: | Jie Xiang, Zhentao Zhang, Shengxi Wu, Keqiang Ye |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Molecular Neurodegeneration |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13024-024-00787-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Utility of different positron emission tomography/computed tomography tracers in the evaluation of incidentally detected dual malignancies: An experience from a tertiary care center
by: Ram Kumar, et al.
Published: (2021-10-01) -
Discordant findings of different positron emission tomography/CT tracers in a case of glioblastoma
by: Ram Kumar, et al.
Published: (2021-10-01) -
Discovery of <i>N</i>-(6-Methoxypyridin-3-yl)quinoline-2-amine Derivatives for Imaging Aggregated α-Synuclein in Parkinson’s Disease with Positron Emission Tomography
by: Haiyang Zhao, et al.
Published: (2025-07-01) -
Positron Emission Tomography Imaging in Sarcoidosis
by: Beth Vettiyil, et al.
Published: (2013-07-01) -
POSITRON EMISSION TOMOGRAPHY IN GYNECOLOGIC ONCOLOGY
by: D. V. Ryzhkova, et al.
Published: (2016-02-01)